Nursing guidelines and discharge planning for patients receiving recombinant interleukin-2.
Caliendo
G
G
Albert Einstein Cancer Center-Montefiore Medical Center, Bronx, NY 10467.
Joyce
D
D
Altmiller
M C
MC
D002318:Cardiovascular Diseases / Q000139:chemically induced; D002985:Clinical Protocols; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000139:chemically induced; D008171:Lung Diseases / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy* / Q000451:nursing*; D009422:Nervous System Diseases / Q000139:chemically induced; D010347:Patient Care Planning; D010351:Patient Discharge; D011994:Recombinant Proteins / Q000627:therapeutic use; D012871:Skin Diseases / Q000139:chemically induced
D007376:Interleukin-2; D011994:Recombinant Proteins